Propanc Biopharma, Inc. PPCBD OTC

Propanc Biopharma, Inc. (PPCBD) reported total assets of $19.63M and total liabilities of $5.73M for quarter ending 2025-06-30, resulting in total equity of $13.91M.

The company held $12.09K in cash and short-term investments. Total debt stood at $1.73M, with net debt of $1.71M. The Debt-to-Equity (D/E) ratio was 0.12 (conservative).

Current ratio is 1.5, indicating strong short-term liquidity. Interest coverage is -14.3x (weak).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (28/100) — Total assets $19.63M and equity $13.91M support the company's competitive scale

Overall SharesGrow Score: 25/100 with 0/7 criteria passed.